Heart Failure Society of America Delivering In-Person Review Course for Physicians Pursuing and Maintaining Advanced Heart Failure and Transplant Cardiology Board Certification in 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WASHINGTON, June 27, 2024 /PRNewswire/ — The Heart Failure Society of America (HFSA) is a leading provider of education and professional development resources for clinicians treating patients with heart failure in the United States. To support these clinicians as they apply for initial Advanced Heart Failure and Transplant Cardiology (AHFTC) certification or re-certification with the America Board of Internal Medicine (ABIM), HFSA will host its AHFTC Board Certification Review July 12-14 in Chicago, Illinois at Loews Chicago O’Hare. This is the only in-person course to support clinicians in the AHFTC subspecialty taking place in 2024, to align with ABIM’s exam date on November 6, 2024.

The HFSA AHFTC Board Certification Review features 2.5 days of lectures, discussions and Q&As, with educational content built on the ABIM AHFTC certification exam blueprint and serving as an in-depth review of the key concepts, guidelines, and clinical practices outlined in the exam. Participants can earn up to 24.50 AMA PRA Category 1 Credits™. Several additional resources will provide participants with a toolbox they can use to study right up until test time.

Participants of the HFSA AHFTC Board Certification Review will receive these takeaway tools and resources:

  • Significant facetime with a faculty of over 20 heart failure experts, including lunchtime discussions
  • Online Question Bank, with questions formatted in ABIM-style
  • OnDemand access to in-person presentations post-meeting
  • Pre-recorded webinars available before and after the live course
  • Interactive session with HARVI, a simulation-based tool for learning about cardiovascular physiology, hemodynamics and therapeutics
  • Curated Reading List

The HFSA AHFTC Board Certification Review is conveniently being held in Chicago right near the airport, to allow for easy travel to and from the course, and to minimize clinicians’ time away from home and work.

For more information on the event, visit hfsa.org/boardreview2024.

About the Heart Failure Society of America

The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.

Media Contact: Laura Poko, 301-798-4493, ext. 226, lpoko@hfsa.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/heart-failure-society-of-america-delivering-in-person-review-course-for-physicians-pursuing-and-maintaining-advanced-heart-failure-and-transplant-cardiology-board-certification-in-2024-302183895.html

SOURCE Heart Failure Society of America

Staff

Recent Posts

Blending Innovation with Tradition: Thailand Brings Holistic Wellness to Expo 2025

BANGKOK, May 16, 2025 /PRNewswire/ -- Within just the first month of Expo 2025 in…

38 minutes ago

LEGACY EDUCATION INC. ACHIEVES RECORD Q3 WITH 50% REVENUE GROWTH AND SURPASSES 3,000 ENROLLED STUDENTS

LANCASTER, Calif., May 15, 2025 /PRNewswire/ -- Legacy Education Inc. (NYSE American: LGCY), a leading…

13 hours ago

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW…

13 hours ago

MediKarma Aligns with CMS National Preventive Health Strategy Through AI-Driven, Prevention-First Implementation Infrastructure

SAN FRANCISCO, May 15, 2025 /PRNewswire/ -- MediKarma, a digital health company specializing in AI-powered…

13 hours ago

Dentegrate AI Powers Growth for 220+ Dental Practices, Doubling New Patient Acquisition

BOSTON, May 15, 2025 /PRNewswire/ -- Dentegrate AI is revolutionizing dental practice growth, with over…

13 hours ago

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating…

14 hours ago